ľ¹ÏÖ±²¥

Moderate aortic stenosis is frequently under‑recognized, yet many patients develop symptoms, myocardial damage, and excess mortality before meeting criteria for severe disease, making consistent surveillance and timely reassessment essential to care. 

On this site, healthcare providers will find practical tools, educational materials, and on‑demand programs developed through the ľ¹ÏÖ±²¥’s heart valve initiatives to support earlier identification of at‑risk patients, optimize longitudinal monitoring, and expand access to emerging therapeutic and research opportunities that may improve outcomes in moderate AS.